Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
D-amino acid oxidase activator (DAOA, also known as G72) is a small protein expressed mostly in the brain, spinal cord, and testis[4]. DAOA physically interacts with D-amino acid oxidase (DAO), an enzyme responsible for degrading D-amino acids like D-serine—a co-agonist at the NMDA (N-methyl-D-aspartate) glutamate receptor[1][2][4]. Through this interaction, DAOA can regulate DAO activity and thus indirectly affect NMDA receptor function. The precise impact of DAOA on DAO remains controversial, with some studies indicating DAOA increases DAO activity while others suggest it decreases or has no effect, depending on cell type, assay conditions, and possibly DAOA isoform[1][2]. DAOA genetic variants have been recurrently linked to schizophrenia and bipolar disorder, making it a molecule of interest in neuropsychiatric research[3][4]. However, its molecular mechanism, cellular localization, and potential as a drug target remain incompletely understood and are complicated by conflicting data and tight regulation in human tissues[1][2].
Modulates the activity of D-amino acid oxidase (DAO), thereby influencing the breakdown of D-serine and affecting NMDA receptor signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-amino acid oxidase activator (DAOA).